Fingerprint
Dive into the research topics of 'High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis
Edward Gane, Fred Poordad, Stanley Wang, Armen Asatryan, Paul Y. Kwo, Jacob Lalezari, David L. Wyles, Tarek Hassanein, Humberto Aguilar, Benedict Maliakkal, Ran Liu, Chih Wei Lin, Teresa I. Ng, Jens Kort, Federico J. Mensa
Research output: Contribution to journal › Article › peer-review
72
Scopus
citations